Skip to main content

National Summit on Quality in General Practice

I attended the National Summit on Quality in General Practice on 31 July 2014, which was held at the RCGP Headquarters in Central London. The event was organised by the RCGP, the Health Foundation, and the BMJ. Among the attendees were Dr Maureen Baker, Chair of the RCGP, Dr Fiona Godlee, Editor of the BMJ, and Dr Richard Vautrey from the BMA's General Practice Committee. The National Summit was facilitated by Judy Oliver.

At the meeting, there were presentations and discussion on the current state of general practice in the UK, the challenges we need to overcome to provide high quality primary care services, the importance of adopting a patient-centred approach in the measurement of quality of care, and how we can make change happen in the current political and economic contexts. Delegates worked in groups to address these issues.

Amongst my group were Anna Damerell, Richard Vautrey, Bryan Fisher, Nick Steele and Tom Duncan.We had a stimulating debate on the many challenges facing general practice - such as a rising volume and increased complexity of workload, reduced funding for general practice, dealing with multi-morbidity, and continuing to provide an accessible and high-quality primary care services.


Dr Fiona Godlee, Editor of the BMJ, speaks about promoting research and innovation in general practice.

Comments

Popular posts from this blog

Improving discharge planning in NHS hospitals

Factors that need to be considered in discharge planning that have been identified in previous projects include:

Ensuring that discharge arrangements are discussed with patients, family members and carers; and that they are given a copy of the discharge summary.Adequate coordination between the hospital, community health services, general practices, and the providers of social care services.There is a follow-up after discharge of patients at high risk of complications or readmission - either in person or by telephone - to ensure that the discharge arrangements are working well. Medicines reconciliation is carried out. This is the process of verifying patient medication lists at a point-of-care transition, such as hospital discharge, to identify which medications have been added, discontinued, or changed from pre-admission medication lists.Ensuring that any outstanding test results at discharge are obtained and passed on to primary care teams; and ensuring there are clear arrangements …

Can GPs issue private prescriptions to NHS patients?

The NHS prescription charge in England is currently £8.40 per item. At this level, many commonly prescribed drugs will cost less than the prescription charge and so some NHS patients may occasionally ask if they can have a private prescription rather than an NHS prescription.

In the past, some GPs have been advised that they could issue both an NHS FP10 and a private prescription, and let the patient decide which to use. But the British Medical Association's General Practice Committee has obtained legal advice that said under the current primary care contract, GPs in England may not issue a private prescription alongside or as an alternative to an NHS FP10 prescription. In any consultation where a GP needs to issue an FP10, the concurrent issue of a private prescription would be a breach of NHS regulations.

The issuing of a private prescription in such circumstances could also be seen as an attempt to deprive the NHS of the funds it would receive from the prescription charge. Fur…

What impact will Brexit have on the UK's life sciences sector?

On Thursday 3 November 2016, I spoke at a seminar at the Imperial College Business School on the topic of the impact of Brexit on the UK's life sciences sector (the NHS, universities, and pharmaceutical and biomedical companies). I emphasised the important role played in the life sciences sector by EU-trained professionals and the need to ensure that the UK continued to attract highly-qualified professionals to work, for example, in our National Health Service. I also discussed the need to increase spending on research and development to ensure that the UK remained a world leader in the biomedical industry. The other speakers at the seminar were Andrew Lansley (former Secretary of State for Health) and Richard Phillips (Director of Healthcare Policy at the Association of British Healthcare industries). The event was chaired by Andrew Brown. A copy of my talk can be viewed on Slideshare.